Suraksha Diagnostic Limited (NSE:SURAKSHA)

India · Delayed Price · Currency is INR

325.00

-2.85 (-0.87%)

Sep 11, 2026, 3:29 PM IST

Market Cap	16.86B +5.5%
Revenue (ttm)	3.25B +23.3%
Net Income	357.98M +7.6%
EPS	6.88 +9.5%
Shares Out	52.08M
PE Ratio	47.06
Forward PE	42.05
Dividend	0.50 (0.15%)
Ex-Dividend Date	Sep 15, 2026

Volume	50,564
Open	330.10
Previous Close	327.85
Day's Range	318.10 - 330.10
52-Week Range	224.10 - 349.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2026

About Suraksha Diagnostic

Suraksha Diagnostic Limited provides pathological and radiological services through diagnostic centers in India. It offers home collection services; pathology services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, haematology, clinical biochemistry and immunology, immunohistochemistry, fluorescence in-situ hybridization, cytogenetics, flow cytometry, newborn screening, and NGS. The company also provides microarray, QF-PCR, FISH, karyotyping, and NIPT services; X-Ray, MRI scan, CT scan, US... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1992

Employees 1,600

Stock Exchange National Stock Exchange of India

Ticker Symbol SURAKSHA

Full Company Profile

Financial Performance

In fiscal year 2026, Suraksha Diagnostic's revenue was 3.10 billion, an increase of 23.13% compared to the previous year's 2.52 billion. Earnings were 321.87 million, an increase of 1.14%.

Financial Statements